Skip to main content
ANAB
NASDAQ Life Sciences

Officer Files to Sell Another $1.85M in Stock, Continuing Recent Trend of Insider Sales

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$54.24
Mkt Cap
$1.578B
52W Low
$11.402
52W High
$72.36
52W Position info
376% above low
Off High info
25% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

AnaptysBio officer Dennis Mulroy has filed a Form 144 indicating intent to sell an additional $1.85 million worth of common stock, extending a pattern of significant insider sales over the past month.


Key Events · Ownership and Investor Activity · ANAB

  • Proposed Stock Sale by Officer

    Officer Dennis Mulroy has filed a Form 144 indicating intent to sell 35,000 shares of common stock, valued at approximately $1.85 million.

  • Continuation of Insider Selling Pattern

    This filing extends a recent trend of significant insider sales by Mr. Mulroy, who has sold approximately $13.18 million worth of shares in the past three months.

  • Shares Acquired via Option Exercise

    The shares intended for sale were acquired through a stock option exercise on the same day as the proposed sale.


Analysis · ANAB · Life Sciences

This Form 144 indicates a significant intent to sell by company officer Dennis Mulroy for approximately $1.85 million. This transaction, while acquired through option exercise, adds to a consistent pattern of insider selling from Mr. Mulroy, who has already sold over $13 million in the last three months. This ongoing distribution by a key insider could signal a desire to monetize holdings following the company's recent spin-off and share repurchase program announcement, potentially creating selling pressure on the stock.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANAB was trading at $54.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Nov 18, 2026, 7:03 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $47.74
Real-time Price: $48.56 info
Change: +$0.820 (+2%) info
Market Cap: $1.409B info
ANAB
Nov 18, 2026, 6:56 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $47.06
Real-time Price: $48.56 info
Change: +$1.50 (+3%) info
Market Cap: $1.409B info
ANAB
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $48.56 info
Change: +$0.790 (+2%) info
Market Cap: $1.409B info
ANAB
Nov 12, 2026, 4:16 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $48.56 info
Change: +$0.790 (+2%) info
Market Cap: $1.409B info
ANAB
Oct 20, 2026, 3:49 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $45.00
Real-time Price: $48.56 info
Change: +$3.56 (+8%) info
Market Cap: $1.409B info